Literature DB >> 26377530

Case Numbers and Process Quality in Breast Surgery in Germany: A Retrospective Analysis of Over 150,000 Patients From 2013 to 2014.

Christina Köster1, Günther Heller, Stephanie Wrede, Thomas König, Steffen Handstein, Joachim Szecsenyi.   

Abstract

BACKGROUND: Numerous studies from around the world have shown a positive association between case numbers and the quality of medical care. The evidence to date suggests that conformity to guidelines for the treatment of patients with breast cancer is better in German hospitals that have higher case numbers.
METHODS: We used data obtained by an external program for quality assurance in inpatient care (externe stationäre Qualitätssicherung, esQS) for the years 2013 and 2014 to investigate seven process indicators in the area of breast surgery, including histologic confirmation of the diagnosis before definitive treatment, axillary dissection as recommended by the guidelines, and an appropriate temporal interval between diagnosis and operation. Case numbers were categorized with the aid of various threshold values. Moreover, subgroup analyses were carried out for patients under age 65, patients in good general health, patients without lymph-node involvement, and patients with a tumor size pT0 or pT1 or an overall tumor size less than 5 cm.
RESULTS: Data on 153,475 patients from 939 hospitals were analyzed. Six of seven indicators had values that were better overall, to a statistically significant extent, in hospitals with higher case numbers. Although this relationship was not consistently seen, the worst results were generally found in the category with the lowest case numbers. Similar though less striking results were obtained in the subgroup analyses. An exception to the general finding was that, in hospitals with higher case numbers, the interval between diagnosis and operation was more often longer than three weeks.
CONCLUSION: Guideline adherence is higher in hospitals that treat more cases. The present study does not address the question whether this, in turn, affects morbidity or mortality. To improve process quality in peripheral hospitals, the quality assurance program should be continued.

Entities:  

Mesh:

Year:  2015        PMID: 26377530      PMCID: PMC4577666          DOI: 10.3238/arztebl.2015.0585

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  22 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Does Center Volume Correlate with Survival from Breast Cancer?

Authors:  Anton Scharl; Uwe-Jochen Göhring
Journal:  Breast Care (Basel)       Date:  2009-08-12       Impact factor: 2.860

3.  Two-sided confidence intervals for the single proportion: comparison of seven methods.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

Review 4.  A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider?

Authors:  G A Gooiker; W van Gijn; P N Post; C J H van de Velde; R A E M Tollenaar; M W J M Wouters
Journal:  Eur J Surg Oncol       Date:  2010-09       Impact factor: 4.424

5.  The effect of hospital volume on the outcome of breast cancer surgery.

Authors:  P Peltoniemi; M Peltola; T Hakulinen; U Häkkinen; L Pylkkänen; K Holli
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

6.  The requirements of a specialist Breast Centre.

Authors:  A R M Wilson; L Marotti; S Bianchi; L Biganzoli; S Claassen; T Decker; A Frigerio; A Goldhirsch; E G Gustafsson; R E Mansel; R Orecchia; A Ponti; P Poortmans; P Regitnig; M Rosselli Del Turco; E J Th Rutgers; C van Asperen; C A Wells; Y Wengström; L Cataliotti
Journal:  Eur J Cancer       Date:  2013-08-19       Impact factor: 9.162

7.  Surgeon and breast unit volume-outcome relationships in breast cancer surgery and treatment.

Authors:  Ailbhe M McDermott; Deirdre M Wall; Peadar S Waters; Shan Cheung; Mark Sibbering; Kieran Horgan; Olive Kearins; Gill Lawrence; Julietta Patnick; Michael J Kerin
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

8.  Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands.

Authors:  Sabine Siesling; Vivianne C G Tjan-Heijnen; Marnix de Roos; Yvonne Snel; Thijs van Dalen; Michel W Wouters; Henk Struikmans; Johannes J M van der Hoeven; John H Maduro; Otto Visser
Journal:  Breast Cancer Res Treat       Date:  2014-08-09       Impact factor: 4.872

9.  Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study.

Authors:  Achim Wöckel; Dominic Varga; Ziad Atassi; Christian Kurzeder; Regine Wolters; Manfred Wischnewsky; Christine Wulff; Rolf Kreienberg
Journal:  Onkologie       Date:  2010-01-22

Review 10.  Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification.

Authors:  Markus Wallwiener; Sara Y Brucker; Diethelm Wallwiener
Journal:  Arch Gynecol Obstet       Date:  2012-06       Impact factor: 2.344

View more
  2 in total

1.  Treatment Quality in Breast Cancer: Numbers, Age, and Breast Reconstruction.

Authors:  Carolin Nestle-Krämling; Christoph Andree
Journal:  Dtsch Arztebl Int       Date:  2015-08-31       Impact factor: 5.594

2.  The requirements of a specialist breast centre.

Authors:  Laura Biganzoli; Fatima Cardoso; Marc Beishon; David Cameron; Luigi Cataliotti; Charlotte E Coles; Roberto C Delgado Bolton; Maria Die Trill; Sema Erdem; Maria Fjell; Romain Geiss; Mathijs Goossens; Christiane Kuhl; Lorenza Marotti; Peter Naredi; Simon Oberst; Jean Palussière; Antonio Ponti; Marco Rosselli Del Turco; Isabel T Rubio; Anna Sapino; Elzbieta Senkus-Konefka; Marko Skelin; Berta Sousa; Tiina Saarto; Alberto Costa; Philip Poortmans
Journal:  Breast       Date:  2020-02-26       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.